|Category||HEALTHCARE PROVIDER – PROFESSIONAL AUDIENCE|
|Entry Title||MULTIPLE MYELOMA ASSESSMENT PATHWAY (M.M.A.P.)|
|Client||Genzyme Canada Inc.|
In multiple myeloma, numerous complex treatment paradigms make decision-making difficult to navigate. Watching Hem/Oncs draw algorithms in Advisory Boards revealed that they all treat differently based on province/centre. We had to somehow ease our product SARCLISA into their algorithm and treatment set. Inspired by the way travel websites help narrow vacation choices, we designed a web-based medical education program that helped Hem/Oncs navigate real-patient-based complex treatment pathways.
|Agency / Company||No Fixed Address Inc.|